TEM: Rata-rata rega prakiraan Tempus AI, Inc.

Logo korporat perusahaan Tempus (TEM)

The Tempus AI, Inc (TEM) business relies on access to massive arrays of medical data and the development of high-precision therapy, while the current indicator stands at 75.20. Stringent FDA requirements and patient privacy laws create significant barriers to entry for new players. The market capitalization trend reflects growth driven by unique AI algorithms, which establish a powerful competitive advantage in genome analysis.

TEM Tempus: Prakiraan konsensus analis ing interval 15.06.2024 - 22.10.2026

Rincian analitis perusahaan Tempus AI (TEM)

Indikator analitis utama Tempus AI, Inc. (TEM):
Rega tempus.com|TEM - Prakiraan konsensus analis|Nilai pasar Tempus AI Inc
Ringkesan analitik perusahaan:Tempus Labs
Produk sing diprodhuksi Tempus AI

For Tempus AI, Inc (TEM), the consensus valuation serves as a filter for market noise, aggregating expert forecasts on the asset's fair value based on discounted cash flow analysis. This indicator reflects market confidence in the scalability of the DNA analysis IT platform, considering minimal environmental costs and server capacity efficiency as factors for long-term business sustainability.

Perusahaan pesaing

Rega prakiraan analis QGEN|Prakiraan konsensus analis IONS (Ionis)|Repligen Corp (RGEN) - Rata-rata rega prakiraan|RNA - Bagan rega target|CRISPR (CRSP) - Target konsensus|WGS: Prakiraan konsensus analis|Prakiraan gabungan firma investasi RARE|Bagan rega target Beam Therapeutics|Prakiraan gabungan firma investasi SRPT (Sarepta Therapeutics)|Prakiraan konsensus analis TWST|Prakiraan konsensus analis 10x (TXG)|Intellia Therapeutics - Target konsensus|Rega prakiraan analis STOK (stoketherapeutics.com)|BioLife Solutions - Prakiraan konsensus analis|Rata-rata rega prakiraan Wave Life Sciences Ltd|Maze Tx (MAZE) - Bagan rega target|Target konsensus Sionna Corp|Bagan rega target Prime Medicine, Inc.|tayshagtx.com - Bagan tingkat prakiraan|Target konsensus QURE (uniQure)|Prakiraan konsensus analis MeiraGTx Holdings (MGTX)|Bagan rega target Regenxbio RGNX|Target median analis Solid Corp (SLDB)|OCGN: Target konsensus|Konsensus nilai wajar PACB (pacb.com)|BNTC: Prakiraan konsensus analis|Design Therapeutics Inc (DSGN) - Prakiraan konsensus analis|RCKT (Rocket Pharmaceuticals Inc) - Prakiraan konsensus analis|4D Molecular Corp (FDMT) - Target median analis|Target konsensus LXEO (Lexeo Therapeutics)|KRRO (korrobio.com) - Konsensus nilai wajar|Prakiraan konsensus analis EDIT (Editas Medicine)|Target median analis Silence Therapeutics PLC (SLN)|PRQR - Bagan rega target|CDXS (Codexis, Inc.) - Prakiraan gabungan firma investasi|SGMO: Prakiraan konsensus analis|Target konsensus Nautilus Bio|Target konsensus MGX|DTIL (Precision BioSciences Inc.) - Rega prakiraan analis|Prakiraan konsensus analis GBIO|BOLD - Rata-rata rega prakiraan|Bagan rega target Exicure XCUR|IMNN - Target konsensus|RXi Pharmaceuticals - Prakiraan konsensus analis|MBIO (Mustang Bio, Inc.) - Prakiraan gabungan firma investasi|transcodetherapeutics.com (RNAZ) - Bagan rega target|Prakiraan gabungan firma investasi BNGO|APDN (Applied DNA Sciences) - Prakiraan konsensus analis|Prakiraan konsensus analis bluebirdbio.com|Target konsensus IPA (ImmunoPrecise Antibodies)|Rega prakiraan analis OMGA|Prakiraan konsensus analis OMIC (Singular Genomics Systems Inc)|Regulus (RGLS) - Rata-rata rega prakiraan|SYRS - Bagan rega target|telesisbio.com (TBIO) - Target konsensus|TRACON Pharmaceuticals, Inc. (TCON) - Bagan rega target|Bagan tingkat prakiraan UBX (Unity Biotechnology Inc.)